EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Highly Sensitive and Specific Panels of Plasma Exosomal microRNAs for Identification of Malignant Pulmonary Nodules

Rui Tao iD, Dandan Wang, Wenjing Pei, Yanfei Liu, Pengcheng Liu, Renming Li, Jiegou Xu, Jing Ye, Dahai Zhao iD

The Clinical Respiratory Journal · 2024-11 · 18 (11)

DOI: 10.1111/crj.70034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Clinical Respiratory Journal, online erschienen am 15.11.2024. Verfasst von Rui Tao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China. Hauptthemen laut MEDLINE: Lung Neoplasms, MicroRNAs, Exosomes, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Research Fund of Anhui Institute of Translational Medicine, Natural Science Research Project of Anhui Universities, Natural Science Foundation of Anhui Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

With wide application of computed tomography (CT) in early lung cancer screening, solitary pulmonary nodules (SPNs) are frequently detected. Due to their high etiological diversity and potential for malignancy, rapid and accurate identification and malignant SPNs are crucial in the clinical management. In the present study, plasma exosomal microRNAs were identified and evaluated as sensitive and specific indicators for malignant SPNs. Materials and Methods Exosomal miRNAs isolated from the plasmas of pathologically confirmed patients with SPN (four malignant and four benign, designated as the screening set) were subjected for high throughput sequencing and eight candidate miRNAs were selected. The pre‐operation plasma levels of the candidate miRNAs in 77 patients with SPN (48 malignant and 29 benign, designated as the identification set) were detected by quantitative PCR, five miRNAs were identified as potential biomarkers for malignant SPNs, and the diagnostic values of the five miRNAs each alone or combined were then analyzed by AUROC analysis. The prediction values of the identified miRNAs were further evaluated in 95 patients with SPN (double blind, 74 malignant and 21 benign, designated as the validation set).

Results

High‐throughput sequencing identified 45 miRNAs with statistical differences between benign and malignant SPNs. Among the eight candidate miRNAs in the identification set, miR‐1‐3p alone had the best diagnostic value, with the sensitivities and specificities of 89.6% and 100% for malignant SPNs. Unexpectedly, when miR‐1‐3p was combined with miR‐99a‐5p, both the sensitivity and specificity reached 100% for malignant SPNs. miR‐1‐3p+miR‐125b‐5p and miR‐1‐3p+miR‐218‐5p were also good indicators of malignant SPNs with sensitivities of 95.8% and 97.9%, specificities of 100% and 96.6%. Further analysis of these microRNA combinations in the validation set indicated that the PPV were 91.4%, 97.4%, and 93.5% and the NPV were 100%, 100%, and 88.9% for miR‐1‐3p+miR‐99a‐5p, miR‐1‐3p+miR‐218‐5p, and miR‐1‐3p+miR‐125b‐5p, with the sensitivities were 100%, 100%, and 97.3% and the specificities were 66.7%, 90.5%, and 76.2% for miR‐1‐3p+miR‐99a‐5p, miR‐1‐3p+miR‐218‐5p, and miR‐1‐3p+miR‐125b‐5p, respectively.

Conclusions

Through high throughput sequencing, qPCR determination of plasma microRNAs and AUROC analysis, miR‐1‐3p combined with miR‐99a‐5p, miR‐125b‐5p, or miR‐218‐5p have been found to be sensitive and specific indicators of malignant SPNs in both the identification and validation sets. Our results indicate that the panels of plasma miRNAs can be used as diagnostic biomarkers for malignant SPNs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsMicroRNAsExosomesBiomarkers, TumorSensitivity and SpecificityHigh-Throughput Nucleotide SequencingHumansFemaleMaleMiddle AgedTomography, X-Ray ComputedAgedSolitary Pulmonary NoduleEarly Detection of CancerAdult

Stichwörter der Autor:innen

diagnostic biomarkersearly diagnosisexosomal microRNAsplasmasolitary pulmonary nodules

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, the Second Affiliated Hospital, Anhui Medical University, Hefei, Anhui Province, China.
  • Department of Immunology, School of Basic Medical Sciences, Anhui Medical University, Hefei, Anhui Province, China.
  • Department of Respiratory and Critical Care Medicine, Anhui Chest Hospital, Thoracic Clinical College of Anhui Medical University, Hefei, Anhui Province, China.

ORCID-Profile: Rui Tao, Dahai Zhao

Förderung

  • Research Fund of Anhui Institute of Translational Medicine
  • Natural Science Research Project of Anhui Universities
  • Natural Science Foundation of Anhui Province
  • Collaborative Chinese and Western Medicine Research Project for Major Difficult Diseases
  • Hefei Municipal Natural Science Foundation

Zitieren

APA

Tao, R., Wang, D., Pei, W., Liu, Y., Liu, P., Li, R., Xu, J., Ye, J., & Zhao, D. (2024). Highly Sensitive and Specific Panels of Plasma Exosomal microRNAs for Identification of Malignant Pulmonary Nodules. The Clinical Respiratory Journal, 18(11). https://doi.org/10.1111/crj.70034

Vancouver

Tao R, Wang D, Pei W, Liu Y, Liu P, Li R, et al. Highly Sensitive and Specific Panels of Plasma Exosomal microRNAs for Identification of Malignant Pulmonary Nodules. The Clinical Respiratory Journal. 2024;18(11). doi:10.1111/crj.70034

BibTeX
@article{Tao2024,
  author = {Tao, Rui and Wang, Dandan and Pei, Wenjing and Liu, Yanfei and Liu, Pengcheng and Li, Renming and Xu, Jiegou and Ye, Jing and Zhao, Dahai},
  title = {Highly Sensitive and Specific Panels of Plasma Exosomal microRNAs for Identification of Malignant Pulmonary Nodules},
  journal = {The Clinical Respiratory Journal},
  year = {2024},
  volume = {18},
  number = {11},
  doi = {10.1111/crj.70034}
}
Kostenlos starten →